Cancer drug delivery put to the test in healthy volunteers
NCT ID NCT07214766
Summary
This study aims to see if two different injection methods for the cancer drug trastuzumab deliver the same amount of medicine into the body. It will involve healthy male volunteers who will receive a single injection. Researchers will measure drug levels and monitor for side effects to compare a standard syringe method with a newer wearable device.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anaheim Clinical Trials
RECRUITINGAnaheim, California, 92801, United States
-
Daytona Beach Clinical Rsch Unit
RECRUITINGDaytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit - Dallas
RECRUITINGDallas, Texas, 75247, United States
-
QPS Bio-Kinetic
RECRUITINGSpringfield, Missouri, 65802-4842, United States
Conditions
Explore the condition pages connected to this study.